AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
182.31
-4.48 (-2.40%)
At close: Jun 27, 2025, 4:00 PM
183.00
+0.69 (0.38%)
After-hours: Jun 27, 2025, 7:59 PM EDT
AbbVie Market Cap
AbbVie has a market cap or net worth of $322.03 billion as of June 27, 2025. Its market cap has increased by 6.98% in one year.
Market Cap
322.03B
Enterprise Value
386.88B
1-Year Change
6.98%
Ranking
Category
Stock Price
$182.31
Market Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $322.03B, an increase of 480.35%. That is a compound annual growth rate of 15.12%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 26, 2025 | 329.95B | 5.07% |
Dec 31, 2024 | 314.02B | 14.77% |
Dec 29, 2023 | 273.61B | -4.27% |
Dec 30, 2022 | 285.80B | 19.40% |
Dec 31, 2021 | 239.37B | 26.54% |
Dec 31, 2020 | 189.17B | 44.48% |
Dec 31, 2019 | 130.93B | -5.58% |
Dec 31, 2018 | 138.67B | -10.18% |
Dec 29, 2017 | 154.39B | 51.71% |
Dec 30, 2016 | 101.76B | 5.08% |
Dec 31, 2015 | 96.84B | -7.12% |
Dec 31, 2014 | 104.26B | 24.10% |
Dec 31, 2013 | 84.01B | 51.40% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 711.28B |
Johnson & Johnson | 366.40B |
Novo Nordisk | 301.06B |
UnitedHealth Group | 273.97B |
Abbott Laboratories | 239.05B |
Novartis AG | 231.01B |
AstraZeneca | 216.45B |
Merck & Co. | 200.05B |